Author

S. V. Ivanov

Observed name: S.V. Ivanov

Institutions: SuperGen (United States), Institute of Biomedical Chemistry

Observed institutions: SuperGen (United States), Institute of Biomedical Chemistry

ORCID: 0000-0003-0438-9108

Observed ORCID: 0000-0003-0438-9108

OpenAlex ID: A5134523565

Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry

2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 4

Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry

2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 3

Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry

2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 2

Fortelyzin in the treatment of minor acute ischemic stroke according to a subanalysis of the observational study FORPI registry

2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics

Fortelyzin in the treatment of acute ischemic stroke due to basilar-artery occlusion: data from the observational study FORPI registry

2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics

Predicting the safety of intravenous thrombolysis with Fortelyzin in patients over 60 years of age with ischemic stroke using the THRIVE scale

2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics

Works count: 6

Citation count: 9

H-index: 2

I10-index: